Innovative Product Launches PCCA has a track record of launching innovative products like Lipoderm and suspendit Anhydrous, presenting opportunities for cross-selling to existing customers and attracting new clients seeking cutting-edge pharmaceutical solutions.
Awards and Recognitions Being recognized as a Top Workplace and receiving multiple awards such as the Social Responsibility Campaign/Program and Crystal Awards not only boosts PCCA's credibility but also opens doors for collaboration with like-minded organizations, enhancing the company's market presence and sales potential.
Partnership with KUNESA GmbH The strategic partnership with KUNESA GmbH provides PCCA with an entry point into integrated pharmacy, lab, and front-end design services, creating opportunities for joint marketing efforts and upselling complementary products to KUNESA's clientele, thereby driving revenue growth.
Long-Standing CFO Transition The transition of the long-standing CFO, Marc DuPont, offers an opportunity for networking with potential clients during the period of transition, leveraging his expertise to build relationships and secure deals before his retirement, ensuring a smooth handover and maintaining client trust.
Consistent Revenue Growth With a revenue range between $50M to $100M, PCCA's consistent financial performance provides a stable platform for expanding sales efforts, allocating resources for new initiatives, and exploring market segments where personalized medicine and compounding products are in high demand.
1-888-653-2347 
support@leadiq.com 
